Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Geron Corporation
GERN | US
1.50
USD0
0%
GERN | US
About Geron Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
1.50
Open
1.52
High
1.54
Low
1.49
Geron Corporation a late-stage clinical biopharmaceutical company focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat a telomerase inhibitor that is in Phase 3 clinical trials which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Geron Corporation was incorporated in 1990 and is headquartered in Foster City California.
View LessGERN | US
Risk
74.2
Sharpe
0.04
Luna's Score
46/100
Recommendation
Hold
Luna says (GERN | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
57.6%1 month
74.2%3 months
77.4%6 months
67.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
8.04
Debt to equity
0.28
Debt to assets
0.19
Ent. to EBITDA
-9.06
Ent. to rev.
1.59K
PEG
-2.38
Other Fundamentals
EBITDA
-226.77M
MarketCap
904.19M
MarketCap(USD)
904.19M
Div. yield
-
Op. margin
-7.86K
Erngs. growth
-
Rev. growth
2.94K
Ret. on equity
-72.56
Short ratio
9.04
Short perc.
13.52
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.33
Range1M
0.46
Range3M
0.72
Volumes: Market Activity
Rel. volume
0.68
Price X volume
18.90M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -9.06 | - | Cheaper |
| Ent. to Revenue | 1,594.86 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 8.04 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 77.37 | - | Par |
| Debt to Equity | 0.28 | -1.23 | Expensive |
| Debt to Assets | 0.19 | 0.25 | Cheaper |
| Market Cap | 904.19M | - | Emerging |
